CORRECTION – CFN Media Examines Medical Marijuana, Inc.’s Investment in Cannabinoid Patent Licenses – SYS


SEATTLE, WA — (Marketwired) — 07/07/16 — In the news release issued Wednesday, July 6, 2016 by CFN Media Group, we are advised by the company that only one of the two patent licenses held by Medical Marijuana, Inc.’s (OTC PINK: MJNA) portfolio company Kannalife™ Sciences is exclusive, rather than both licenses being exclusive as originally issued. Complete corrected text follows.

CFN Media Examines Medical Marijuana, Inc.’s Investment in Cannabinoid

... read more at: http://www.sys-con.com/node/3867869